DSM and CVC in Join hands for polymer intermediates and composite resins

摘要

Royal DSM, the Life Sciences and Materials Sciences company, and CVC Capital Partners (CVC), one of the world's leading investment advisory firms, have announced a partnership for DSM's activities in Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins through the formation of a new company, provisionally called NewCo. The NewCo will be 65% owned by CVC and 35% by DSM, with 1,950 employees Pro-forma third-party sales of NewCo in 2014 amounted to ?2.1 bin with a 2014 EBITDA of ?106 mln.